Hedy Kindler to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Hedy Kindler has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.211
-
Pancreatic cancer: an update. Curr Oncol Rep. 2007 May; 9(3):170-6.
Score: 0.072
-
In focus: advanced pancreatic cancer. Clin Adv Hematol Oncol. 2005 May; 3(5):420-2.
Score: 0.063
-
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance). Clin Cancer Res. 2013 Dec 15; 19(24):6957-66.
Score: 0.028
-
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin Cancer Res. 2012 Jan 15; 18(2):577-84.
Score: 0.025
-
Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303). Cancer. 2012 Jan 15; 118(2):571-8.
Score: 0.024